News | August 04, 2022
Merck KGaA posts higher earnings, profits across business segments
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
Despite the price increases for raw materials and logistics, EBITDA pre rose organically by 3.2% to € 1,782 million
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
The company will invest approximately €440 million to increase membrane manufacturing capacity in Carrigtwohill and to build a new manufacturing facility at Blarney Business Park, both in Cork, Ireland
Q1 net sales increased by 12.2% to € 5,198 million compared with the year-earlier quarter
Company expects strong organic growth in sales, EBITDA in 2022
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
Danny Bar-Zohar will become Global Head of R&D and Joern-Peter Halle will become Chief Strategy Officer
The transaction is expected to close in the first quarter of 2022
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
Subscribe To Our Newsletter & Stay Updated
